APO RESEARCH · REPORT
Bacteriophage
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Product & engineering
Understand the product.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Selected research
Industry Research
Bacteriophage Industry Research Report 2026
Market perspective
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The United States is the largest consumer market, accounting for about 38%, and Europe is the second largest market, accounting for about 26%.
The market for Bacteriophage is fragmented with players such as NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS) , Qingdao Phagepharm Bio-tech,. Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage and so on. Among them, the top 5 manufacturers with about 34% revenue market share.
Read the full market overview
Report Scope
This report quantifies the global Bacteriophage market in terms of revenue (US$ million) and, where applicable, service volume (L), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bacteriophage.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bacteriophage Market by Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Bacteriophage Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Bacteriophage Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Bacteriophage Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacteriophage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacteriophage and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacteriophage.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bacteriophage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DsDNA Bacteriophage
- SsDNA Bacteriophage
- SsRNA Bacteriophage
- Others
Applications
- Animal Health
- Aquaculture
- Agriculture
- Food Industry
- Human Health
- Others
Companies covered
- NPO Microgen
- Proteon Pharmaceuticals
- Phagelux
- Intralytix
- Micreos
- Eliava BioPreparations
- Locus Biosciences,Inc
- Pharmex Group,LLC
- Pherecydes Pharma
- APS Biocontrol Ltd. (APS)
- Qingdao Phagepharm Bio-tech
- Fixed-Phage Limited
- Zeptometrix
- Phage International, Inc.
- MicroMir
- iNtODEWORLD, Inc.
- NEXTBIOTICS
- Armata Pharmaceuticals, Inc.
- Innophage
- Adaptive Phage Therapeutics
- TechnoPhage
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bacteriophage by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 DsDNA Bacteriophage
- 2.2.3 SsDNA Bacteriophage
- 2.2.4 SsRNA Bacteriophage
- 2.2.5 Others
- 2.3 Bacteriophage by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Animal Health
- 2.3.3 Aquaculture
- 2.3.4 Agriculture
- 2.3.5 Food Industry
- 2.3.6 Human Health
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Bacteriophage Breakdown Data by Type
- 3.1 Global Bacteriophage Historic Market Size by Type (2021-2026)
- 3.2 Global Bacteriophage Forecasted Market Size by Type (2027-2032)
4 Bacteriophage Breakdown Data by Application
- 4.1 Global Bacteriophage Historic Market Size by Application (2021-2026)
- 4.2 Global Bacteriophage Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bacteriophage Market Perspective (2021-2032)
- 5.2 Global Bacteriophage Growth Trends by Region
- 5.2.1 Global Bacteriophage Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bacteriophage Historic Market Size by Region (2021-2026)
- 5.2.3 Bacteriophage Forecasted Market Size by Region (2027-2032)
- 5.3 Bacteriophage Market Dynamics
- 5.3.1 Bacteriophage Industry Trends
- 5.3.2 Bacteriophage Market Drivers
- 5.3.3 Bacteriophage Market Challenges
- 5.3.4 Bacteriophage Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bacteriophage Players by Revenue
- 6.1.1 Global Top Bacteriophage Players by Revenue (2021-2026)
- 6.1.2 Global Bacteriophage Revenue Market Share by Players (2021-2026)
- 6.2 Global Bacteriophage Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bacteriophage Head Office and Area Served
- 6.4 Global Bacteriophage Players, Product Type & Application
- 6.5 Global Bacteriophage Manufacturers Established Date
- 6.6 Global Bacteriophage Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bacteriophage Market Size (2021-2032)
- 7.2 North America Bacteriophage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bacteriophage Market Size by Country (2021-2026)
- 7.4 North America Bacteriophage Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bacteriophage Market Size (2021-2032)
- 8.2 Europe Bacteriophage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bacteriophage Market Size by Country (2021-2026)
- 8.4 Europe Bacteriophage Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bacteriophage Market Size (2021-2032)
- 9.2 Asia-Pacific Bacteriophage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bacteriophage Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bacteriophage Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bacteriophage Market Size (2021-2032)
- 10.2 South America Bacteriophage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bacteriophage Market Size by Country (2021-2026)
- 10.4 South America Bacteriophage Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bacteriophage Market Size (2021-2032)
- 11.2 Middle East & Africa Bacteriophage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bacteriophage Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bacteriophage Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 NPO Microgen
- 12.1.1 NPO Microgen Company Information
- 12.1.2 NPO Microgen Business Overview
- 12.1.3 NPO Microgen Revenue in Bacteriophage Business (2021-2026)
- 12.1.4 NPO Microgen Bacteriophage Product Portfolio
- 12.1.5 NPO Microgen Recent Developments
- 12.2 Proteon Pharmaceuticals
- 12.2.1 Proteon Pharmaceuticals Company Information
- 12.2.2 Proteon Pharmaceuticals Business Overview
- 12.2.3 Proteon Pharmaceuticals Revenue in Bacteriophage Business (2021-2026)
- 12.2.4 Proteon Pharmaceuticals Bacteriophage Product Portfolio
- 12.2.5 Proteon Pharmaceuticals Recent Developments
- 12.3 Phagelux
- 12.3.1 Phagelux Company Information
- 12.3.2 Phagelux Business Overview
- 12.3.3 Phagelux Revenue in Bacteriophage Business (2021-2026)
- 12.3.4 Phagelux Bacteriophage Product Portfolio
- 12.3.5 Phagelux Recent Developments
- 12.4 Intralytix
- 12.4.1 Intralytix Company Information
- 12.4.2 Intralytix Business Overview
- 12.4.3 Intralytix Revenue in Bacteriophage Business (2021-2026)
- 12.4.4 Intralytix Bacteriophage Product Portfolio
- 12.4.5 Intralytix Recent Developments
- 12.5 Micreos
- 12.5.1 Micreos Company Information
- 12.5.2 Micreos Business Overview
- 12.5.3 Micreos Revenue in Bacteriophage Business (2021-2026)
- 12.5.4 Micreos Bacteriophage Product Portfolio
- 12.5.5 Micreos Recent Developments
- 12.6 Eliava BioPreparations
- 12.6.1 Eliava BioPreparations Company Information
- 12.6.2 Eliava BioPreparations Business Overview
- 12.6.3 Eliava BioPreparations Revenue in Bacteriophage Business (2021-2026)
- 12.6.4 Eliava BioPreparations Bacteriophage Product Portfolio
- 12.6.5 Eliava BioPreparations Recent Developments
- 12.7 Locus Biosciences,Inc
- 12.7.1 Locus Biosciences,Inc Company Information
- 12.7.2 Locus Biosciences,Inc Business Overview
- 12.7.3 Locus Biosciences,Inc Revenue in Bacteriophage Business (2021-2026)
- 12.7.4 Locus Biosciences,Inc Bacteriophage Product Portfolio
- 12.7.5 Locus Biosciences,Inc Recent Developments
- 12.8 Pharmex Group,LLC
- 12.8.1 Pharmex Group,LLC Company Information
- 12.8.2 Pharmex Group,LLC Business Overview
- 12.8.3 Pharmex Group,LLC Revenue in Bacteriophage Business (2021-2026)
- 12.8.4 Pharmex Group,LLC Bacteriophage Product Portfolio
- 12.8.5 Pharmex Group,LLC Recent Developments
- 12.9 Pherecydes Pharma
- 12.9.1 Pherecydes Pharma Company Information
- 12.9.2 Pherecydes Pharma Business Overview
- 12.9.3 Pherecydes Pharma Revenue in Bacteriophage Business (2021-2026)
- 12.9.4 Pherecydes Pharma Bacteriophage Product Portfolio
- 12.9.5 Pherecydes Pharma Recent Developments
- 12.10 APS Biocontrol Ltd. (APS)
- 12.10.1 APS Biocontrol Ltd. (APS) Company Information
- 12.10.2 APS Biocontrol Ltd. (APS) Business Overview
- 12.10.3 APS Biocontrol Ltd. (APS) Revenue in Bacteriophage Business (2021-2026)
- 12.10.4 APS Biocontrol Ltd. (APS) Bacteriophage Product Portfolio
- 12.10.5 APS Biocontrol Ltd. (APS) Recent Developments
- 12.11 Qingdao Phagepharm Bio-tech
- 12.11.1 Qingdao Phagepharm Bio-tech Company Information
- 12.11.2 Qingdao Phagepharm Bio-tech Business Overview
- 12.11.3 Qingdao Phagepharm Bio-tech Revenue in Bacteriophage Business (2021-2026)
- 12.11.4 Qingdao Phagepharm Bio-tech Bacteriophage Product Portfolio
- 12.11.5 Qingdao Phagepharm Bio-tech Recent Developments
- 12.12 Fixed-Phage Limited
- 12.12.1 Fixed-Phage Limited Company Information
- 12.12.2 Fixed-Phage Limited Business Overview
- 12.12.3 Fixed-Phage Limited Revenue in Bacteriophage Business (2021-2026)
- 12.12.4 Fixed-Phage Limited Bacteriophage Product Portfolio
- 12.12.5 Fixed-Phage Limited Recent Developments
- 12.13 Zeptometrix
- 12.13.1 Zeptometrix Company Information
- 12.13.2 Zeptometrix Business Overview
- 12.13.3 Zeptometrix Revenue in Bacteriophage Business (2021-2026)
- 12.13.4 Zeptometrix Bacteriophage Product Portfolio
- 12.13.5 Zeptometrix Recent Developments
- 12.14 Phage International, Inc.
- 12.14.1 Phage International, Inc. Company Information
- 12.14.2 Phage International, Inc. Business Overview
- 12.14.3 Phage International, Inc. Revenue in Bacteriophage Business (2021-2026)
- 12.14.4 Phage International, Inc. Bacteriophage Product Portfolio
- 12.14.5 Phage International, Inc. Recent Developments
- 12.15 MicroMir
- 12.15.1 MicroMir Company Information
- 12.15.2 MicroMir Business Overview
- 12.15.3 MicroMir Revenue in Bacteriophage Business (2021-2026)
- 12.15.4 MicroMir Bacteriophage Product Portfolio
- 12.15.5 MicroMir Recent Developments
- 12.16 iNtODEWORLD, Inc.
- 12.16.1 iNtODEWORLD, Inc. Company Information
- 12.16.2 iNtODEWORLD, Inc. Business Overview
- 12.16.3 iNtODEWORLD, Inc. Revenue in Bacteriophage Business (2021-2026)
- 12.16.4 iNtODEWORLD, Inc. Bacteriophage Product Portfolio
- 12.16.5 iNtODEWORLD, Inc. Recent Developments
- 12.17 NEXTBIOTICS
- 12.17.1 NEXTBIOTICS Company Information
- 12.17.2 NEXTBIOTICS Business Overview
- 12.17.3 NEXTBIOTICS Revenue in Bacteriophage Business (2021-2026)
- 12.17.4 NEXTBIOTICS Bacteriophage Product Portfolio
- 12.17.5 NEXTBIOTICS Recent Developments
- 12.18 Armata Pharmaceuticals, Inc.
- 12.18.1 Armata Pharmaceuticals, Inc. Company Information
- 12.18.2 Armata Pharmaceuticals, Inc. Business Overview
- 12.18.3 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Business (2021-2026)
- 12.18.4 Armata Pharmaceuticals, Inc. Bacteriophage Product Portfolio
- 12.18.5 Armata Pharmaceuticals, Inc. Recent Developments
- 12.19 Innophage
- 12.19.1 Innophage Company Information
- 12.19.2 Innophage Business Overview
- 12.19.3 Innophage Revenue in Bacteriophage Business (2021-2026)
- 12.19.4 Innophage Bacteriophage Product Portfolio
- 12.19.5 Innophage Recent Developments
- 12.20 Adaptive Phage Therapeutics
- 12.20.1 Adaptive Phage Therapeutics Company Information
- 12.20.2 Adaptive Phage Therapeutics Business Overview
- 12.20.3 Adaptive Phage Therapeutics Revenue in Bacteriophage Business (2021-2026)
- 12.20.4 Adaptive Phage Therapeutics Bacteriophage Product Portfolio
- 12.20.5 Adaptive Phage Therapeutics Recent Developments
- 12.21 TechnoPhage
- 12.21.1 TechnoPhage Company Information
- 12.21.2 TechnoPhage Business Overview
- 12.21.3 TechnoPhage Revenue in Bacteriophage Business (2021-2026)
- 12.21.4 TechnoPhage Bacteriophage Product Portfolio
- 12.21.5 TechnoPhage Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst